These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 9605165

  • 1. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 2. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 3. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 4. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD, Alsenz J, Esparza I, Hack CE, Lambris JD.
    Biochemistry; 1992 Feb 18; 31(6):1787-94. PubMed ID: 1371073
    [Abstract] [Full Text] [Related]

  • 5. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T, Okada M, Matsumoto M, Hong KS, Kinoshita T, Atkinson JP.
    Mol Immunol; 1991 Oct 18; 28(10):1137-47. PubMed ID: 1833639
    [Abstract] [Full Text] [Related]

  • 6. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 18; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 7. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J, Yadav VN, Phulera S, Kamble A, Gautam AK, Panwar HS, Sahu A.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724763
    [Abstract] [Full Text] [Related]

  • 8. Regulation of complement activity by vaccinia virus complement-control protein.
    McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM.
    J Infect Dis; 1992 Dec 01; 166(6):1245-50. PubMed ID: 1431243
    [Abstract] [Full Text] [Related]

  • 9. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG, Melamed J, Arnaout MA.
    Eur J Immunol; 1983 Jun 01; 13(6):465-70. PubMed ID: 6222909
    [Abstract] [Full Text] [Related]

  • 10. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME, Nussenzweig V.
    J Exp Med; 1984 Jun 01; 159(6):1669-85. PubMed ID: 6233387
    [Abstract] [Full Text] [Related]

  • 11. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD, Newman SL, Lambris JD, Devery-Pocius JE, Cain JA, Lachmann PJ.
    J Exp Med; 1983 Aug 01; 158(2):334-52. PubMed ID: 6224880
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 13. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF, Prince GM, Gaither TA, Frank MM.
    J Immunol; 1985 Oct 01; 135(4):2673-9. PubMed ID: 3161945
    [Abstract] [Full Text] [Related]

  • 14. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V, Wessberg S, Leikola J.
    Complement Inflamm; 1989 Oct 01; 6(4):270-80. PubMed ID: 2527715
    [Abstract] [Full Text] [Related]

  • 15. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
    Ahmad M, Raut S, Pyaram K, Kamble A, Mullick J, Sahu A.
    J Immunol; 2010 Nov 15; 185(10):6128-37. PubMed ID: 20956343
    [Abstract] [Full Text] [Related]

  • 16. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW, Farrell SA.
    J Immunol; 1991 Jan 15; 146(2):656-62. PubMed ID: 1670949
    [Abstract] [Full Text] [Related]

  • 17. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T, Lavoie S, Nussenzweig V.
    J Immunol; 1985 Apr 15; 134(4):2564-70. PubMed ID: 3156184
    [Abstract] [Full Text] [Related]

  • 18. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
    Vedeler CA, Matre R, Iversen BM.
    Int Arch Allergy Appl Immunol; 1990 Apr 15; 92(1):60-3. PubMed ID: 2147176
    [Abstract] [Full Text] [Related]

  • 19. Complement receptor is an inhibitor of the complement cascade.
    Iida K, Nussenzweig V.
    J Exp Med; 1981 May 01; 153(5):1138-50. PubMed ID: 6910481
    [Abstract] [Full Text] [Related]

  • 20. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S, Pangburn MK.
    Eur J Immunol; 1990 Dec 01; 20(12):2555-61. PubMed ID: 2148521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.